Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Curia | Contract Pharma

What are you searching for?

Sign in

Search by

Curia

Curia

Company Headquarters

24 Corporate Circle, Albany, NY, 12203, US

Driving Directions Phone: View Phone Fax: View Fax
View website

Company Description

Curia is a CDMO with over 30 years of experience, 20+ global sites and 3,000 employees. Our small molecules, generic APIs and biologics offerings span discovery to commercialization, with integrated regulatory and analytical capabilities. Our state-of-the-art facilities enable efficient drug manufacturing, accelerating life-changing therapeutics.

Request more information from Curia

Request more information from Curia

Categories from Curia

Accelerated Stability Studies
ADMET
Analytical Laboratory Services
Analytical Methods Development
Analytical Validation Studies
Animal Health
API Solubilization Technologies
Aseptic Processing
Assay Development
Bioanalytical Analysis LC/MS/MS
Bioanalytical Services
Biocatalysis
Biologics Process Development
Bioprocess Validation
Bioprocessing
Biosimilars
Cell Line Construction & Development
cGMP Synthesis
Chemical Analysis
Chemistry, Combinatorial
Chemistry, Medicinal
Chiral Separations, R&D
Chromatographic Analysis, LC/GC
Chromatography
CMC (Chemistry, Manfacturing & Controls)
Consulting, Regulatory
Container Testing
Contaminant Analysis
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Contract Packaging
Contract Research
Custom Manufacturing
Custom Synthesis
DMF Establishment / Maintenance
Dosage Form Development
Downstream Processing
Drug Delivery Systems
Drug Design
Drug Development Services
Drug Discovery Support Services
Drug Screening
Excipients
Fermentation
Filling, Cartridge
Filling, Syringe
Filling, Vial
Formulation Development
Formulation Services
Granulation
High Throughput Screening
In Vivo Testing
IND/NDA Submissions
Lead Optimization
Library Synthesis
Lipids/Phospholipids
Litigation Support & Discovery
Lyophilization
Mammalian Cell Culture
Manufacturing, Antibody-Drug Conjugates
Manufacturing, API
Manufacturing, API, High Potency
Manufacturing, Aseptic Fill/Finish
Manufacturing, Biologics
Manufacturing, Controlled Substances
Manufacturing, Custom
Manufacturing, Cytotoxic & High Potency Compounds
Manufacturing, Dose Form, Non-Sterile
Manufacturing, Dose Form, Sterile
Manufacturing, Generics
Manufacturing, Injectables
Manufacturing, Liquids
Manufacturing, Lyophilized Products
Manufacturing, Ophthalmics
Manufacturing, OTC
Manufacturing, Parenterals, Large Volume
Manufacturing, Parenterals, Small Volume
Manufacturing, Powders, Non-Sterile
Manufacturing, Powders, Sterile
Manufacturing, Solid Dosage
Manufacturing, Solutions & Suspensions
Manufacturing, Syringes, Pre-filled
Manufacturing, Vaccines
Medicinal Chemistry
Metabolic Analysis
Methods Development
Methods Validation
Microbial Fermentation
Micronization
Microscopic Analysis
Mixing & Blending
Packaging, Certification
Packaging, Closures
Packaging, Design & Testing
Packaging, Form/Fill/Seal
Packaging, Injectables
Packaging, Parenterals
Packaging, Services, Other
Packaging, Unit Dosage
Parenterals Development
Parenterals, Syringe Filling
Parenterals, Vial Filling
Particle Characterization
Particle Size Analysis
Particle Size Classification
Pharmacology
Physical Testing
Pilot-Scale Filling
Preclinical Testing
Preclinical Testing Formulations
Preformulation
Process Analytical Technology (PAT)
Process Characterization
Process Development/Scale-Up Services
Process R&D
Process Validation Studies
Protein Synthesis
Protein Synthesis, Solid State
Purification
Quality Control Testing
R&D Services
Raw Materials Analysis
Regulatory Affairs Consultants
RNAi Technology
Scale-Up
Screening, Classifying
Spray Drying
Stability Studies
Stability, ICH
Sterile Filling
Sterility Testing
Sterilization
Storage
Supplier, Fine Chemicals
Syringe Filling
Technology Transfer
Toxicology Services & Analysis
Training: cGMP/HPB/FDA Compliance
Trays, Vial Filling
Validation, Clinical
Validation, Equipment Cleaning
Validation, Filtration
Validation, Manufacturing
Validation, Services
Wet Chemical Analysis
X-Ray Crystallography
X-Ray Powder Diffraction
X-Ray Spectroscopy

Content From Curia

Elevating Pharmaceutical Contracting

Ebook

Elevating Pharmaceutical Contracting

Unleashing Excellence in Quality, Supply Chain, HPAPIs & Orphan Drugs.

Released By Curia

The Shift Towards US Pharmaceutical Manufacturing — Considerations in Attaining the Right Global Mix

White Papers / Tech Papers

The Shift Towards US Pharmaceutical Manufacturing — Considerations in Attaining the Right Global Mix

Effective strategies to secure and de-risk pharmaceutical supply chains and how Curia assures the continual production of urgently needed drugs.

Released By Curia

HPAPI Development and Manufacturing Trends

Ebook

HPAPI Development and Manufacturing Trends

The current trend of increased potency of drug substances is driving the need for better cleaning methods to reduce cross contamination.

Released By Curia

Related Content

Breaking News

Curia Opens Expanded New Mexico Manufacturing Campus

$200M investment boosts sterile injectable drug production capacity in Albuquerque.

By: Charlie Sternberg

Breaking News

Telix to Buy ITM in $1.65B Radiopharma Deal

The acquisition adds isotope production, manufacturing, and late-stage therapeutic assets to Telix’s radiopharmaceutical platform.

By: Charlie Sternberg

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

Breaking News

Novo Nordisk to Acquire Three Obesity Drug Programs from Kallyope

Deal adds non-incretin obesity assets, including IND-ready peptide candidate K-554, as Novo seeks to broaden its metabolic pipeline.

By: Charlie Sternberg

Breaking News

Fareva Expands CDMO Network With Türkiye Site

The Lüleburgaz facility adds major production capacity, technical expertise, and international client reach.

By: Charlie Sternberg

Breaking News

Eli Lilly Completes AtaiBeckley Acquisition

Deal adds BPL-003, AtaiBeckley’s lead program for treatment-resistant depression.

By: Charlie Sternberg

Features

Inside the Changing HPAPI Manufacturing Landscape

Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.

By: Charlie Sternberg

Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius

The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.

By: Tim Wright

Breaking News

European Consortium Validates Continuous API Manufacturing Platform

The project aims to support faster scale-up, stronger process control and more flexible API manufacturing.

By: Charlie Sternberg

Collaborations & Alliances

Neuland, Gland Pharma Partner on Sterile API Manufacturing

Dedicated suite at Gland Pharma’s Visakhapatnam facility will support Neuland’s growing sterile API customer demand.

By: Charlie Sternberg

Breaking News

Körber Releases PAS-X MES 3.4.2 for Pharma Manufacturing

The latest version of Körber’s PAS-X Manufacturing Execution System adds expanded shopfloor capabilities, deployment automation, infrastructure efficiency improvements and more.

By: Charlie Sternberg

Breaking News

Cambrex High Point Site Clears FDA, PMDA, TGA Inspections

High Point facility can now support approved API manufacturing for the U.S., Japan and Australia.

By: Charlie Sternberg

Breaking News

MedPharm Expands End-to-End Proteomic Analysis Capabilities with Olink Certification

Certification adds targeted multiplex protein biomarker analysis to MedPharm’s research and translational testing capabilities.

By: Tim Wright

Breaking News

IAG Cargo Adds Kuala Lumpur to Pharma Network

New GDP-certified station at Kuala Lumpur International Airport expands IAG Cargo’s Constant Climate coverage in Southeast Asia.

By: Charlie Sternberg

Breaking News

IASO Bio Acquires MediSix Therapeutics

Deal adds MediSix’s PEBL platform, T-cell engineering expertise, and clinical-stage pipeline to IASO Bio’s global cell therapy strategy.

By: Charlie Sternberg

Collaborations & Alliances

Innovent Adds Vanflyta to China Oncology Portfolio

Agreement with Daiichi Sankyo gives Innovent exclusive commercialization rights for the FLT3 inhibitor in China.

By: Charlie Sternberg